Large-scale meta-analysis of genome-wide association data identifies six new risk loci for Parkinson’s disease

Cited by (1,004)

Items 201–300 of 1,004

1. NeuroChip, an updated version of the NeuroX genotyping platform to rapidly screen for variants associated with neurological diseases
   Cornelis Blauwendraat, Faraz Faghri, Lasse Pihlstrøm, Joshua T. Geiger, Alexis Elbaz, Suzanne Lesage, Jean‐Christophe Corvol, Patrick May, Aude Nicolas, Yevgeniya A. Abramzon et al. · 2017 · Neurobiology of Aging
2. Sleep Disturbance as Potential Risk and Progression Factor for Parkinson’s Disease
   Nicolaas Ida Bohnen, Michele T.M. Hu · 2019 · Journal of Parkinson s Disease
3. Aberrant epigenome in iPSC‐derived dopaminergic neurons from Parkinson's disease patients
   Rubén Fernández‐Santiago, Iria Carballo‐Carbajal, Giancarlo Castellano, Roger Torrent, Yvonne Richaud, Adriana Sánchez‐Danés, Roser Vilarrasa‐Blasi, Álex Sánchez‐Pla, José Luis Mosquera, Jordi Soriano et al. · 2015 · EMBO Molecular Medicine
4. Accuracy Improvement for Predicting Parkinson’s Disease Progression
   Mehrbakhsh Nilashi, Othman Ibrahim, Ali Ahani · 2016 · Scientific Reports
5. LRRK2 Pathways Leading to Neurodegeneration
   Mark Cookson · 2015 · Current Neurology and Neuroscience Reports
6. Balancing Apoptosis and Autophagy for Parkinson’s Disease Therapy: Targeting BCL-2
   Jia Liu, Weijing Liu, Hui Yang · 2018 · ACS Chemical Neuroscience
7. “LRRK2: Autophagy and Lysosomal Activity”
   Marta Madureira, Natalie Connor‐Robson, Richard Wade‐Martins · 2020 · Frontiers in Neuroscience
8. The Role of Co-chaperones in Synaptic Proteostasis and Neurodegenerative Disease
   Erica L. Gorenberg, Sreeganga S. Chandra · 2017 · Frontiers in Neuroscience
9. Parkinson Disease from Mendelian Forms to Genetic Susceptibility: New Molecular Insights into the Neurodegeneration Process
   Amin Karimi Moghadam, Saeid Charsouei, Benjamin Bell, Mohammad Reza Jabalameli · 2018 · Cellular and Molecular Neurobiology
10. Single-cell RNA-seq of mouse dopaminergic neurons informs candidate gene selection for sporadic Parkinson disease
    Hook, Paul W., McClymont, Sarah A., Cannon, Gabrielle H., Law, William D., Morton, A. Jennifer, Goff, Loyal A., McCallion, Andrew S. · 2018 · The American Journal of Human Genetics
11. Role of the endolysosomal system in Parkinson’s disease
    D. J. Vidyadhara, John E. Lee, Sreeganga S. Chandra · 2019 · Journal of Neurochemistry
12. Current Aspects of the Endocannabinoid System and Targeted THC and CBD Phytocannabinoids as Potential Therapeutics for Parkinson’s and Alzheimer’s Diseases: a Review
    Ruwini Cooray, Veer Bala Gupta, Cenk Suphioglu · 2020 · Molecular Neurobiology
13. The Emerging Role of the Lysosome in Parkinson’s Disease
    Alba Navarro-Romero, Marta Montpeyó, Marta Martínez‐Vicente · 2020 · Cells
14. Tryptophan Metabolites Are Associated With Symptoms and Nigral Pathology in Parkinson's Disease
    Patrick L. Heilman, Ernest W. Wang, Mechelle M. Lewis, Stanisław Krzyżanowski, Colt D. Capan, Amanda Rae Burmeister, Guangwei Du, Martha L. Escobar Galvis, Patrik Brundin, Xuemei Huang et al. · 2020 · Movement Disorders
15. Integrative analyses of proteomics and RNA transcriptomics implicate mitochondrial processes, protein folding pathways and GWAS loci in Parkinson disease
    Alexandra Dumitriu, Javad Golji, Adam Thomas Labadorf, Benbo Gao, Thomas G. Beach, Richard H. Myers, Kenneth A. Longo, Jeanne C. Latourelle · 2015 · BMC Medical Genomics
16. Genetics of Parkinson disease
    Aloysius Domingo, Christine Klein · 2018 · Handbook of clinical neurology
17. Untitled work
    Turner · 2004 · 10.1002/(issn)1099-0968
18. Neuropathology of α‐synuclein propagation and braak hypothesis
    Heather McCann, Heidi Cartwright, Glenda Margaret Halliday · 2015 · Movement Disorders
19. Age-Dependent Dopaminergic Neurodegeneration and Impairment of the Autophagy-Lysosomal Pathway in LRRK-Deficient Mice
    Emilie Giaime, Youren Tong, Lisa K. Wagner, Yuan Hui Yang, Guodong Huang, Jie Shen · 2017 · Neuron
20. LRRK2 and mitochondria: Recent advances and current views
    Alpana Singh, Lianteng Zhi, Hui Zhang · 2018 · Brain Research
21. The role of monogenic genes in idiopathic Parkinson’s disease
    Xylena Reed, Sara Bandrés‐Ciga, Cornelis Blauwendraat, Mark Cookson · 2018 · Neurobiology of Disease
22. Autophagy and Parkinson’s Disease
    Lu, Jiahong, Wu, Mingyue, Yue, Zhenyu · 2020 · Advances in Experimental Medicine and Biology
23. Differential Aging Analysis in Human Cerebral Cortex Identifies Variants in TMEM106B and GRN that Regulate Aging Phenotypes
    Rhinn, Herve, Abeliovich, Asa · 2017 · Cell Systems
24. LRRK2 inhibitors induce reversible changes in nonhuman primate lungs without measurable pulmonary deficits
    Marco A. S. Baptista, Kalpana Merchant, Ted Barrett, Sakshi Bhargava, Dianne K. Bryce, J. Michael Ellis, Anthony A. Estrada, Matthew J. Fell, Brian K. Fiske, Reina N. Fuji et al. · 2020 · Science Translational Medicine
25. Losing ground: Frontostriatal atrophy disrupts language embodiment in Parkinson's and huntington's disease
    Birba, Agustina, García-Cordero, Indira, Kozono, Giselle, Legaz, Agustina, Ibáñez, Agustín, Sedeño, Lucas, García, Adolfo M. · 2017 · Neuroscience & Biobehavioral Reviews
26. Pathological Influences on Clinical Heterogeneity in Lewy Body Diseases
    David G. Coughlin, Howard I. Hurtig, David John Irwin · 2019 · Movement Disorders
27. In Situ Peroxidase Labeling and Mass-Spectrometry Connects Alpha-Synuclein Directly to Endocytic Trafficking and mRNA Metabolism in Neurons
    Chee Yeun Chung, Vikram Khurana, S. Stephen Yi, Nidhi Sahni, Ken H. Loh, Pavan Kumar Auluck, Valeriya Baru, Namrata D. Udeshi, Yelena Freyzon, Steven A. Carr et al. · 2017 · Cell Systems
28. Genome-wide survival study identifies a novel synaptic locus and polygenic score for cognitive progression in Parkinson’s disease
    Liu, Ganqiang, Peng, Jiajie, Liao, Zhixiang, Locascio, Joseph J., Corvol, Jean-Christophe, Zhu, Frank, Dong, Xianjun, Maple-Grødem, Jodi, Campbell, Meghan C., Elbaz, Alexis et al. · 2021 · Nature Genetics
29. Neuropathology of incidental Lewy body & prodromal Parkinson’s disease
    Thomas Koeglsperger, Svenja-Lotta Rumpf, Patricia Schließer, Felix L. Struebing, Matthias Brendel, Johannes Levin, Claudia Trenkwalder, Günter U. Höglinger, Jochen Wolfgang Herms · 2023 · Molecular Neurodegeneration
30. Parkinson’s disease and bacteriophages as its overlooked contributors
    George V. Tetz, Stuart M. Brown, Yuhan Hao, Victor Tetz · 2018 · Scientific Reports
31. Genome-wide association analysis of self-reported events in 6135 individuals and 252 827 controls identifies 8 loci associated with thrombosis
    David A. Hinds, Alfonso Buil, Daniel Ziemek, Ángel Martínez-Pérez, Rainer Malik, Lasse Folkersen, Marine Germain, Anders Mälarstig, Andrew Anand Brown, José Manuel Soria et al. · 2016 · Human Molecular Genetics
32. Genetic architecture of epigenetic and neuronal ageing rates in human brain regions
    Ake Tzu-Hui Lu, Eilis J. Hannon, Morgan E. Levine, Eileen M. Crimmins, Katie Lunnon, Jonathan S. Mill, Daniel H. Geschwind, Steve Horvath · 2017 · Nature Communications
33. Multi-ancestry genome-wide gene–smoking interaction study of 387,272 individuals identifies new loci associated with serum lipids
    Amy R. Bentley, Understanding Society Scientific Group, Lifelines Cohort, Yun J. Sung, Michael R. Brown, Thomas W. Winkler, Aldi T. Kraja, Ιωάννα Ντάλλα, Karen Schwander, Daniel I. Chasman et al. · 2019 · Nature Genetics
34. Update on the Genetics of Dystonia
    Katja Lohmann, Christine Klein · 2017 · Current Neurology and Neuroscience Reports
35. Phosphoinositides: Regulators of Nervous System Function in Health and Disease
    Padinjat Raghu, Annu Joseph, Harini Krishnan, Pramod Kumar Singh, Sankhanil Saha · 2019 · Frontiers in Molecular Neuroscience
36. Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?
    Yvette C. Wong, Kelvin C. Luk, Kerry Purtell, Samuel Burke, A. Jon Stoessl, Louis‐Éric Trudeau, Zhenyu Yue, Dimitri Krainc, Wolfgang Hermann Oertel, Jose Angel Obeso et al. · 2019 · Movement Disorders
37. Genome-wide association study of Parkinson’s disease in East Asians
    Jia Nee Foo, Louis C.S. Tan, Ishak Darryl Irwan, Wing‐Lok Au, Hui Qi Low, Kumar‐M. Prakash, Azlina Ahmad‐Annuar, Jin‐Xin Bei, Anne Y. Y. Chan, Chiung‐Mei Chen et al. · 2016 · Human Molecular Genetics
38. Genome-Scale Networks Link Neurodegenerative Disease Genes to α-Synuclein through Specific Molecular Pathways
    Vikram Khurana, Jian Peng, Chee Yeun Chung, Pavan Kumar Auluck, Saranna Fanning, Daniel F. Tardiff, Theresa Bartels, Martina Koeva, Stephen W. Eichhorn, Hadar Benyamini et al. · 2017 · Cell Systems
39. Neurodegeneration and the ordered assembly of α-synuclein
    Maria Grazia Spillantini, Michel Goedert · 2017 · Cell and Tissue Research
40. Mitochondria, lysosomes, and dysfunction: their meaning in neurodegeneration
    Matteo Audano, Anja Schneider, Nico Mitro · 2018 · Journal of Neurochemistry
41. The landscape of multiscale transcriptomic networks and key regulators in Parkinson’s disease
    Wang, Qian, Zhang, Yuanxi, Wang, Minghui, Song, Won-Min, Shen, Qi, McKenzie, Andrew, Choi, Insup, Zhou, Xianxiao, Pan, Ping-Yue, Yue, Zhenyu et al. · 2019 · Nature Communications
42. A growth-factor-activated lysosomal K+ channel regulates Parkinson’s pathology
    Wie, Jinhong, Liu, Zhenjiang, Song, Haikun, Tropea, Thomas F., Yang, Lu, Wang, Huanhuan, Liang, Yuling, Cang, Chunlei, Aranda, Kimberly, Lohmann, Joey et al. · 2021 · Nature
43. PPM1H phosphatase counteracts LRRK2 signaling by selectively dephosphorylating Rab proteins
    Berndsen, Kerryn, Lis, Pawel, Yeshaw, Wondwossen M, Wawro, Paulina S, Nirujogi, Raja S, Wightman, Melanie, Macartney, Thomas, Dorward, Mark, Knebel, Axel, Tonelli, Francesca et al. · 2019 · eLife
44. Leucine regulates autophagy via acetylation of the mTORC1 component raptor
    Sung Min Son, So Jung Park, Eleanna Stamatakou, Mariella Vicinanza, Fiona M. Menzies, David Chaim Rubinsztein · 2020 · Nature Communications
45. Mitochondrial Ca2+ Signaling in Health, Disease and Therapy
    Lorenzo Modesti, Alberto Danese, Veronica Angela Maria Vitto, Daniela Ramaccini, Gianluca Aguiari, Roberta Gafà, Giovanni Lanza, Carlotta Giorgi, Paolo Pinton · 2021 · Cells
46. Exploring the Association Between Rosacea and Parkinson Disease
    Alexander Egeberg, Peter Riis Hansen, Gunnar Gislason, Jacob Pontoppidan Thyssen · 2016 · JAMA Neurology
47. Retinal thinning associates with nigral dopaminergic loss in de novo Parkinson disease
    Jeeyun Ahn, Jee‐Young Lee, Tae Wan Kim, Eun Jin Yoon, Sohee Oh, Yu Kyeong Kim, Jong‐Min Kim, Se Joon Woo, Ki Woong Kim, Beomseok Jeon · 2018 · Neurology
48. Ufbp1 promotes plasma cell development and ER expansion by modulating distinct branches of UPR
    Huabin Zhu, Brinda Bhatt, Sathish Sivaprakasam, Yafei Cai, SiYang Maggie Liu, Sai Karthik Kodeboyina, Nikhil Patel, Natasha M. Savage, Ashok Kumar Sharma, Randal J. Kaufman et al. · 2019 · Nature Communications
49. NEAT1 is overexpressed in Parkinson's disease substantia nigra and confers drug‐inducible neuroprotection from oxidative stress
    Alon Simchovitz, Mor Hanan, Naomi Niederhoffer, Nimrod Madrer, Nadav Yayon, Estelle R. Bennett, David Greenberg, Sebastián Kadener, Hermona Soreq · 2019 · The FASEB Journal
50. Parkinson's disease correlates with promoter methylation in the α‐synuclein gene
    Lasse Pihlstrøm, Victoria Berge‐Seidl, Aina Haugen Rengmark, Mathias Toft · 2014 · Movement Disorders
51. A genomic approach to therapeutic target validation identifies a glucose-lowering GLP1R variant protective for coronary heart disease
    Robert A. Scott, Daniel F. Freitag, Li Li, Audrey Y. Chu, Praveen Surendran, Robin Young, Niels Grarup, Alena Stančáková, Yuning Chen, Tibor V. Varga et al. · 2016 · Science Translational Medicine
52. Parkinson’s disease and pesticides: A meta-analysis of disease connection and genetic alterations
    Hussien Ahmed, Abdelrahman Ibrahim Abushouk, Mohamed Gabr, Ahmed Negida, Mohamed M. Abdel‐Daim · 2017 · Biomedicine & Pharmacotherapy
53. Association of Polygenic Risk Score With Cognitive Decline and Motor Progression in Parkinson Disease
    Kimberly C. Paul, Jessica Schulz, Jeff M. Bronstein, Christina M. Lill, Beate R. Ritz · 2018 · JAMA Neurology
54. Genome-wide analyses as part of the international FTLD-TDP whole-genome sequencing consortium reveals novel disease risk factors and increases support for immune dysfunction in FTLD
    Cyril P. Pottier, Yingxue Ren, Ralph B. Perkerson, Matt C. Baker, Gregory D. Jenkins, Marka van Blitterswijk, Mariely DeJesus‐Hernandez, Jeroen van Rooij, Melissa Erin Murray, Elizabeth A. Christopher et al. · 2019 · Acta Neuropathologica
55. α-Synuclein in Parkinson’s disease: causal or bystander?
    Peter Franz Riederer, Daniela Berg, Nicolas Casadei, Fubo Cheng, Joseph Claßen, Christian Dresel, Wolfgang H. Jost, Rejko Krüger, Thomas H. Müller, Heinz Reichmann et al. · 2019 · Journal of Neural Transmission
56. Discovery and functional prioritization of Parkinson’s disease candidate genes from large-scale whole exome sequencing
    Iris E. Jansen, Hui Ye, Sasja Heetveld, Marie C. Lechler, Helen Michels, Renée I. Seinstra, Steven J Lubbe, Valérie Drouet, Suzanne Lesage, Elisa Majounie et al. · 2017 · Genome biology
57. Mitochondrial dysfunction and increased glycolysis in prodromal and early Parkinson's blood cells
    Amy M. Smith, Constanze Depp, Brent James Ryan, Geoffrey I. Johnston, Javier Alegre‐Abarrategui, Samuel G. Evetts, Michal Rolinski, Fahd Baig, Claudio Ruffmann, Anna Katharina Simon et al. · 2018 · Movement Disorders
58. LRRK2 interacts with the vacuolar-type H+-ATPase pump a1 subunit to regulate lysosomal function
    Rebecca L. Wallings, Natalie Connor‐Robson, Richard Wade‐Martins · 2019 · Human Molecular Genetics
59. Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalk
    Yam Nath Paudel, Efthalia Angelopoulou, Christina Piperi, Mohd. Farooq Shaikh, Iekhsan Othman · 2019 · Pharmacological Research
60. Epigenetic regulation in Parkinson’s disease
    Catherine Labbé, Oswaldo Lorenzo‐Betancor, Owen A. Ross · 2016 · Acta Neuropathologica
61. Rescue of α-synuclein aggregation in Parkinson’s patient neurons by synergistic enhancement of ER proteostasis and protein trafficking
    Iva Stojkovska, Willayat Yousuf Wani, Friederike Zunke, Nandkishore R. Belur, Egor A. Pavlenko, Nkatha Mwenda, Karan Sharma, Laetitia Francelle, Joseph R. Mazzulli · 2021 · Neuron
62. RAB32 Ser71Arg in autosomal dominant Parkinson's disease: linkage, association, and functional analyses
    Gustavsson, Emil K, Follett, Jordan, Trinh, Joanne, Barodia, Sandeep K, Real, Raquel, Liu, Zhiyong, Grant-Peters, Melissa, Fox, Jesse D, Appel-Cresswell, Silke, Stoessl, A Jon et al. · 2024 · The Lancet Neurology
63. Parkinson’s disease-linked D620N VPS35 knockin mice manifest tau neuropathology and dopaminergic neurodegeneration
    Xi Chen, Jennifer K. Kordich, Erin T. Williams, Nathan D. Levine, Allyson Cole-Strauss, Lee L. Marshall, Viviane Labrie, Jiyan Ma, Jack W. Lipton, Darren J. Moore · 2019 · Proceedings of the National Academy of Sciences
64. Gut microbiome and Parkinson's disease: Perspective on pathogenesis and treatment
    Safa Salim, Fatima Ali Ahmad, Ayesha Banu, Farhan Mohammad · 2022 · Journal of Advanced Research
65. Epidemiology and diagnostic testing for hemochromatosis and iron overload
    Paul C. Adams · 2015 · International Journal of Laboratory Hematology
66. Genetics of neurodegenerative diseases: an overview
    Lasse Pihlstrøm, Sarah Wiethoff, Henry Houlden · 2017 · Handbook of clinical neurology
67. Dystonia and Parkinson's disease: What is the relationship?
    Aakash S. Shetty, Kailash P. Bhatia, Anthony Edward Lang · 2019 · Neurobiology of Disease
68. Kynurenine pathway in Parkinson's disease—An update
    Dhivya Venkatesan, Mahalaxmi Iyer, Arul Narayanasamy, Kamalakannan Siva, Balachandar Vellingiri · 2020 · eNeurologicalSci
69. Parkinson’s disease: experimental models and reality
    Peizhou Jiang, Dennis W. Dickson · 2017 · Acta Neuropathologica
70. The NINDS Parkinson's disease biomarkers program
    Liana S. Rosenthal, Daniel F. Drake, Roy N. Alcalay, Debra Babcock, F. DuBois Bowman, Alice S. Chen‐Plotkin, Ted M. Dawson, Richard B. Dewey, Dwight C. German, Xuemei Huang et al. · 2015 · Movement Disorders
71. The Interplay between Alpha-Synuclein Clearance and Spreading
    Tomás Lopes da Fonseca, Anna Villar‐Piqué, Tiago F. Outeiro · 2015 · Biomolecules
72. How can rAAV ‐α‐synuclein and the fibril α‐synuclein models advance our understanding of Parkinson's disease?
    Laura A. Volpicelli‐Daley, Deniz Kirik, Lindsay E. Stoyka, David G. Standaert, Ashley S. Harms · 2016 · Journal of Neurochemistry
73. Tau in the Pathophysiology of Parkinson’s Disease
    Lina Pan, Lanxia Meng, Mingyang He, Zhentao Zhang · 2021 · Journal of Molecular Neuroscience
74. Curcumin-driven reprogramming of the gut microbiota and metabolome ameliorates motor deficits and neuroinflammation in a mouse model of Parkinson’s disease
    Can Cui, Yingying Han, Hongxia Li, Hongxiang Yu, Bei Zhang, Gang Li · 2022 · Frontiers in Cellular and Infection Microbiology
75. A Dementia-Associated Risk Variant near TMEM106B Alters Chromatin Architecture and Gene Expression
    Michael D. Gallagher, Marijan Posavi, Peng Huang, Travis L. Unger, Yosef Berlyand, Analise L. Gruenewald, Alessandra Chesi, Elisabetta Manduchi, Andrew D. Wells, Struan F.A. Grant et al. · 2017 · The American Journal of Human Genetics
76. Elevated GM3 plasma concentration in idiopathic Parkinson’s disease: A lipidomic analysis
    Robin Chan, Adler Perotte, Bowen Zhou, Christopher Liong, Evan Shorr, Karen S. Marder, Un Jung Kang, Cheryl Waters, Oren A. Levy, Yimeng Xu et al. · 2017 · PLoS ONE
77. Potential Modes of Intercellular α-Synuclein Transmission
    Dario Valdinocci, Rowan A. W. Radford, Sue Maye Siow, Roger S. Chung, Dean L. Pountney · 2017 · International Journal of Molecular Sciences
78. Mitophagy and reactive oxygen species interplay in Parkinson’s disease
    Bin Xiao, Joshua Kuruvilla, Eng‐King Tan · 2022 · npj Parkinson s Disease
79. Role of α-synuclein in microglia: autophagy and phagocytosis balance neuroinflammation in Parkinson’s disease
    Qian-Kun Lv, Kang‐Xin Tao, Xiao-Bo Wang, Xiao‐Yu Yao, Meng‐Zhu Pang, Junyi Liu, Fen Wang, Chun‐Feng Liu · 2023 · Inflammation Research
80. DNA methylation in Parkinson's disease
    Wüllner, Ullrich, Kaut, Oliver, deBoni, Laura, Piston, Dominik, Schmitt, Ina · 2016 · Journal of Neurochemistry
81. β2‐adrenoceptor agonists and antagonists and risk of Parkinson's disease
    Naomi Gronich, Darrell R. Abernethy, Eitan Auriel, Idit Lavi, Gad Rennert, Walid Saliba · 2018 · Movement Disorders
82. Aberrant mitochondrial morphology and function associated with impaired mitophagy and DNM1L-MAPK/ERK signaling are found in aged mutant Parkinsonian LRRK2R1441Gmice
    Huifang Liu, Philip Wing‐Lok Ho, Chi-Ting Leung, Shirley Yin-Yu Pang, Eunice Eun Seo Chang, Zoe Yuen-Kiu Choi, Michelle Hiu-Wai Kung, David Boyer Ramsden, Shu‐Leong Ho · 2020 · Autophagy
83. Implications of DNA Methylation in Parkinson’s Disease
    Ernesto G. Miranda-Morales, Karin Meier, Ada Agustina Sandoval-Carrillo, Jose Manuel Salas-Pacheco, Paola Vázquez-Cárdenas, Óscar Arias-Carrión · 2017 · Frontiers in Molecular Neuroscience
84. Dysregulated phosphorylation of Rab GTPases by LRRK2 induces neurodegeneration
    Ga Ram Jeong, Eun-Hae Jang, Jae Ryul Bae, Soyoung Jun, Ho Chul Kang, Chi‐Hu Park, Joo‐Ho Shin, Yukio Yamamoto, Keiko Tanaka, Valina Lynn Dawson et al. · 2018 · Molecular Neurodegeneration
85. Variants in GBA , SNCA , and MAPT influence Parkinson disease risk, age at onset, and progression
    Albert A. Davis, Kristin M. Andruska, Bruno A. Benítez, Brad Alan Racette, Joel S. Perlmutter, Carlos Cruchaga · 2015 · Neurobiology of Aging
86. Lateralisation in Parkinson disease
    Peter Franz Riederer, K. A. Jellinger, Pierre Luc Kolber, Géraldine Hipp, Jeswinder Sian‐Hülsmann, Rejko Krüger · 2018 · Cell and Tissue Research
87. LRRK2‐mediated Rab10 phosphorylation in immune cells from Parkinson's disease patients
    Atashrazm, Farzaneh, Hammond, Deborah, Perera, Gayathri, Bolliger, Marc F., Matar, Elie, Halliday, Glenda M., Schüle, Birgitt, Lewis, Simon J.G., Nichols, R. Jeremy, Dzamko, Nicolas · 2019 · Movement Disorders
88. The usual suspects, dopamine and alpha‐synuclein, conspire to cause neurodegeneration
    Danielle E. Mor, Malcolm J. Daniels, Harry Ischiropoulos · 2019 · Movement Disorders
89. Genetic, Structural, and Functional Evidence Link TMEM175 to Synucleinopathies
    Lynne Krohn, Tuğba Nur Öztürk, Benoît Vanderperre, Bouchra Ouled Amar Bencheikh, Jennifer A. Ruskey, Sandra B. Laurent, Dan Spiegelman, Ronald B. Postuma, Isabelle Arnulf, Michele T. M. Hu et al. · 2019 · Annals of Neurology
90. LRRK2 and the Endolysosomal System in Parkinson’s Disease
    Madalynn L. Erb, Darren J. Moore · 2020 · Journal of Parkinson s Disease
91. Characterizing the Genetic Architecture of Parkinson's Disease in Latinos
    Douglas P. Loesch, Andréa R. V. R. Horimoto, Karl Heilbron, Elif Irem Sarihan, Miguel Inca‐Martinez, Emily Mason, Mario Cornejo‐Olivas, Luis Torres, Pilar Mazzetti, Carlos Cosentino et al. · 2021 · Annals of Neurology
92. Insights into VPS13 properties and function reveal a new mechanism of eukaryotic lipid transport
    Marianna Leonzino, Karin M. Reinisch, Pietro V. De Camilli · 2021 · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids
93. Presynaptic autophagy is coupled to the synaptic vesicle cycle via ATG-9
    Sisi Yang, Daehun Park, Laura Manning, Sarah E. Kargbo-Hill, Mian Cao, Xuan Zhao, Ian J. Gonzalez, Yongming Dong, Benjamin Clark, Lin Shao et al. · 2022 · Neuron
94. Meta‐analyses identify differentially expressed microRNAs in Parkinson's disease
    Jessica Schulz, Petros Takousis, Inken Wohlers, Ivie Itua, Valerija Dobričić, Gerta Rücker, Harald Binder, Lefkos T. Middleton, John P. A. Ioannidis, Robert Perneczky et al. · 2019 · Annals of Neurology
95. Therapeutics in the Pipeline Targeting α-Synuclein for Parkinson's Disease
    Hilary Grosso Jasutkar, Stephanie E. Oh, M. Maral Mouradian · 2022 · Pharmacological Reviews
96. Effects of 3D culturing conditions on the transcriptomic profile of stem-cell-derived neurons
    Halil Tekin, Sean Simmons, Beryl B. Cummings, Linyi Alex Gao, Xian Adiconis, Cynthia C. Hession, Ayan Ghoshal, Danielle Ashley Dionne, Sourav Choudhury, Volkan Yesilyurt et al. · 2018 · Nature Biomedical Engineering
97. The Genetics of Dementia with Lewy Bodies: Current Understanding and Future Directions
    Tatiana Orme, Rita João Guerreiro, José Brás · 2018 · Current Neurology and Neuroscience Reports
98. Molecular Mechanisms Underlying Synaptic and Axon Degeneration in Parkinson’s Disease
    Gcwensa, Nolwazi Z., Russell, Drèson L., Cowell, Rita M., Volpicelli-Daley, Laura A. · 2021 · Frontiers in Cellular Neuroscience
99. c-Abl and Parkinson’s Disease: Mechanisms and Therapeutic Potential
    Saurav Brahmachari, Senthilkumar S. Karuppagounder, Preston Ge, Saebom Lee, Valina Lynn Dawson, Ted M. Dawson, Han Seok Ko · 2017 · Journal of Parkinson s Disease
100. Moving beyond neurons: the role of cell type-specific gene regulation in Parkinson’s disease heritability
     Regina Hertfelder Reynolds, Juan Antonio Botía, Mike A. Nalls, Alastair John Noyce, Aude Nicolas, Mark Cookson, Sara Bandrés‐Ciga, Jesse Raphael Gibbs, Dena G. Hernandez, Andrew Singleton et al. · 2019 · npj Parkinson s Disease